Abstract It is well recognized that the renin-angiotensin system (RAS) exists not only as circulating, paracrine (cell to cell), but also intracrine (intracellular) system. In the kidney, however, it is difficult to dissect the respective contributions of circulating RAS versus intrarenal RAS to the physiological regulation of proximal tubular Na + reabsorption and hypertension. Here, we review recent studies to provide an update in this research field with a focus on the proximal tubular RAS in angiotensin II (ANG II)-induced hypertension. Careful analysis of available evidence supports the hypothesis that both local synthesis or formation and AT 1 (AT 1a ) receptor-and/or megalin-mediated uptake of angiotensinogen (AGT), ANG I and ANG II contribute to high levels of ANG II in the proximal tubules of the kidney. Under physiological conditions, nearly all major components of the RAS including AGT, prorenin, renin, ANG I, and ANG II would be filtered by the glomerulus and taken up by the proximal tubules. In ANG II-dependent hypertension, the expression of AGT, prorenin, and (pro)renin receptors, and angiotensinconverting enzyme (ACE) is upregulated rather than downregulated in the kidney. Furthermore, hypertension damages the glomerular filtration barrier, which augments the filtration of circulating AGT, prorenin, renin, ANG I, and ANG II and their uptake in the proximal tubules.
Introduction
High blood pressure, i.e., hypertension, is one of the most important courses of cardiovascular diseases, stroke, and chronic renal failure [1] [2] [3] . The impact and significance of hypertension in humans are best recognized by the facts that one in three US adults will eventually develop hypertension or take antihypertensive drugs in their lifetime, and that economically, prevention and treatment of hypertension cost US$>100 billion a year [1] [2] [3] . The prevalence of hypertension in Americans aged 60 or older is much higher with over 65 % of this population having high blood pressure, accordingly to National Heart Lung Blood Institute (NHLBI). It is surprising, however, that only one in two of hypertensive patients have their blood pressure under adequate control with current antihypertensive drugs [1, 2, 4, 5] . The mechanisms underlying the development and progression of hypertension and the reasons underlying the difficulty in controlling hypertension in some hypertensive patients remain incompletely understood [1, 5, 6] . It is now well accepted that genetics, endocrine disorders, dietary, lifestyle, as well as environmental factors, all independently contribute to the development of hypertension. Yet, accordingly to NHLBI, the known genetic factors for hypertension may only account for <3 % of all causes combined. Indeed, although over 50 common genetic variants or loci associated with blood pressure or hypertension were recently identified by human genome-wide association studies (GWAS), the role of each of these genetic variant/locus in, and to what extent each of these genetic variants would contribute to, hypertension remain largely unknown [6] [7] [8] [9] [10] . One thing is clear, however, that regardless of the cause(s) whether it is due to genetics, endocrine disorders, lifestyle, or environmental factors, the development, progression, and maintenance of most, if not all, forms of hypertension appear to converge and depend on a final common pathway or mechanism, namely increased body salt and fluid retention due to the inability of the kidney to excrete excessive salt and fluid loads in the presence of high blood pressure, or impaired pressure natriuresis responses and resetting the pressure natriuresis relationship to higher pressures [11-15, 16••] .
Among all tubular segments in the kidney, the proximal tubules perhaps play the most critical role in maintaining body sodium (Na + ) and fluid balance and normal blood pressure by regulating pressure natriuresis responses under physiological conditions, as well as in the development and maintenance of hypertension by promoting Na + and fluid retention and resetting the pressure natriuresis responses to higher pressures [13, 15, [17] [18] [19] . Indeed, the proximal tubules are responsible for reabsorbing ∼70 % of filtered Na + and H 2 O from the glomeruli; thus, sustained increases in Na + reabsorption in the proximal tubules by a few percentage points will ultimately cause Na + retention, with consequence of increased body fluid volume and blood pressure. Several key factors play important roles in regulating Na + reabsorption in the proximal tubules of the kidney and blood pressure, namely angiotensin II (ANG II) via AT 1 receptors [18, 20• [36] [37] [38] [39] , atrial natriuretic peptides via NPR A and NPR B receptors [40] [41] [42] [43] , and renal sympathetic nervous activity [44] [45] [46] are also involved in the regulation of proximal tubule Na + reabsorption and blood pressure; nevertheless, the roles of these humoral factors are beyond the scope of discussions in this article.
The objectives of this article are to review recent research advances in studying the roles of circulating and proximal tubule cellular ANG II via AT 1 receptors [18, 20• The primary emphases will be on (a) whether ANG II in the proximal tubules of the kidney is derived from local onsite formation or from receptor-mediated uptake of circulating and/or local paracrine ANG II or its substrate angiotensinogen (AGT) and key enzymes renin (and prorenin), (b) whether a functional intracellular ANG II system exists in the proximal tubules of the kidney, and (c) whether NHE3 in the proximal tubules of the kidney plays an important role in the regulation of proximal tubular Na + reabsorption and blood pressure and is required for the development of ANG II-induced hypertension. All of these important issues still remain incompletely understood. It is hoped that this review may serve as a catalyst to stimulate further studies and constructive debates, and improve our understanding of how circulating, paracrine, and intracellular ANG II acts independently or through interactions to regulate proximal tubular Na + reabsorption and blood pressure under physiological conditions. The demonstrated roles of NHE3 in the proximal tubules of the kidney in maintaining normal basal blood pressure and in ANG II-induced hypertension may also help devise novel strategies to target NHE3 in the proximal tubules in treating ANG II-dependent hypertension or resistant hypertension associated with persistent body salt and fluid retention.
Intratubular or Intracellular Expression and Biosynthesis of the RAS in the Proximal Tubules
The proximal tubules of the kidney have long been recognized as a major target of both circulating and local paracrine ANG II under physiological conditions as well as in hypertension [17, [47] [48] [49] [50] [51] [52] . The concept of an intratubular renin-angiotensin system (RAS) in the kidney, especially in the proximal tubules, remains firmly established in renal physiology and hypertension [51] [52] [53] [54] [55] [56] . Indeed, extensive research during last two decades has shown that all major components of the classical RAS, including the sole substrate AGT, two key enzymes renin and angiotensin-converting enzyme (ACE), and two major G protein-coupled receptor (GPCR) subtypes of AT 1 and AT 2 , are expressed or localized in the proximal tubules of the kidney [57] [58] [59] [60] [61] [62] [63] . The expression of AGT, renin, and ACE in the proximal tubules is essential for the onsite production of intratubular and intracellular ANG II, whereas the localization of AT 1 and AT 2 receptors in the proximal tubules plays a key role in mediating biological and physiological effects of ANG II. Moreover, in addition to AT 1 and AT 2 for ANG II and/or ANG III (des-aspartyl-ANG II) [25, 64, 65] , two additional receptors have been identified in the proximal tubules of the kidney, including the Mas receptors for ANG fragments, ANG (1-7) [66••, 67] , and the AT 4 receptors (or insulin-regulated aminopeptidase (IRAP)) for ANG (3-8) [68] [69] [70] . Using quantitative in vitro and in vivo autoradiography, we have localized most, if not all, of major components of the RAS in the kidney [61, [70] [71] [72] [73] [74] [75] [76] [77] . Active renin, ACE, AT 1 , AT 2 , ANG (1-7) or Mas, and AT 4 receptors are all localized in the superficial cortex of the kidney, primarily in the proximal tubules (Fig. 1) .
The presence of an intratubular and intracellular RAS in the proximal tubules of the kidney is also strongly supported by reports that the levels of AGT, ANG I, and ANG II in the proximal tubular fluid often greatly exceed those of plasma and the whole kidney [60, 78, 79] . Earlier studies have demonstrated AGT messenger RNA (mRNA) expression in the proximal tubules of the rat and sheep kidneys, which suggests that AGT may be synthesized locally in the proximal tubules [80] [81] [82] . To estimate the levels of AGT protein and activity in the proximal tubules, Navar's group was instrumental in collecting proximal tubular fluid samples from the rat kidney using the micropuncture technique, and incubated them with excess renin to generate ANG I [60] . These authors demonstrated that the level of AGT was greater than the circulating level. More direct evidence was provided by the study of Braam et al., in which the authors first blocked the glomerular filtrate delivery into the proximal tubule to exclude the sources of circulating AGT, ANG I, and ANG II that were filtered through the glomerulus [79] . The tubular fluid was directly collected from the downstream segment of the perfused proximal tubule for measurement of ANG I and ANG II, showing ANG I and ANG II levels in the nanomolar concentrations in the proximal tubular fluid [79] .
The additional line of the evidence that supports the hypothesis of intratubular and intracellular synthesis of the RAS in the kidney is derived from extensive studies in ANG IIinduced hypertension. Unlike the circulating RAS, which is inversely regulated by increased ANG II and blood pressure, the intratubular RAS in the proximal tubules of the kidney is differentially regulated in ANG II-dependent hypertension [53, 61, 76, [83] [84] [85] . Angiotensinogen [53, 55, 83] , ACE [61] , ANG II [86] [87] [88] 89 ••], and AT 1 receptors [61, 87, 89 ••], were all significantly upregulated, rather than downregulated, in ANG II-induced hypertension. In spontaneously hypertensive rats, ANG II also increased AT 1 receptors in the proximal tubule cells [90] . This dysregulation of the local RAS biosynthesis or expression in the proximal tubules, along with recently reported enhancement of prorenin/renin and (pro)renin receptors (PRR) in the collecting ducts of the kidney during ANG II-induced hypertension [91] [92] [93] , strongly supports a feedforward mechanism of intrarenal or intratubular RAS in the development of ANG II-dependent hypertension [53] [54] [55] .
AT 1 (AT 1a ) Receptor-or Multi-ligand Endocytic Receptor Megalin-Mediated Uptake of the Circulating RAS Components in the Proximal Tubules Although it has been recognized for decades that high levels of ANG II found in the kidney are primarily due to intratubular and/or intracellular biosynthesis of the RAS in the kidney, recent studies suggests that GPCR-or non GPCR-mediated uptake of major components of the circulating RAS, including AGT [94••, 95] , prorenin and renin [96••] , and ANG II [77, [86] [87] [88] [97] [98] [99] [100] , may also contribute to high levels of the RAS proteins in the kidney.
Angiotensinogen
AGT is the primary substrate for the rate-limiting enzyme renin with a molecular weight of ∼63 kDa. Human AGT has 452 amino acids, but rat and mouse AGT may vary slightly from human form [101] [102] [103] [104] . AGT is reportedly expressed in nearly all tissues; nevertheless, the liver remains to be the primary site of its expression or production. However, AGT has been localized in the kidney [80, 105, 106] , where most of AGT mRNAs and proteins are primarily detected by electron microscopic immunohistochemistry in the apical membranes [63] of proximal convoluted and straight tubules of the cortex [80] . Although glomerular mesangial cells and medullary vascular bundles occasionally show AGT mRNAs or AGT immunopositive staining in neonatal rats, there is no solid evidence to suggest that they are expressed at low to moderate levels in the glomeruli, mesangial cells, or distal nephron segments of adult rats under physiological conditions [80] .
Whether AGT proteins in the kidney are derived from the liver AGT or produced intratubularly or intracellularly remain an issue of current debate. AGT with a molecular weight of ∼63 kDa was previously considered to be too large to cross the glomerular filtration barrier. However, AGT concentrations in the proximal tubular fluid of anesthetized rats are much higher than ANG I and/or ANG II, suggesting local synthesis or secretion of AGT by the proximal tubules [53] . AGT mRNAs and proteins are indeed abundantly expressed in the kidney at least during ANG II-induced hypertension [55, [107] [108] [109] . Kobori et al. infused human angiotensinogen into normotensive rats to study whether the circulating AGT is filtered through the glomeruli, and detected no human AGT in the urine, supporting the notion that AGT may be too large to cross the glomerular membranes [109] . Recently, an elegant study using mutant mice with liver-or kidney-specific knockout (KO) of AGT has provided new insights and perspectives into this debate [94••] . Matsusaka et al. generated two different strains of mutant mice, one with liver AGT-KO and the other with kidney AGT-KO, to compare AGT levels in the kidney in wild-type, liver AGT-KO and kidney AGT-KO mice [94••] . These authors demonstrated that mice with kidney-specific AGT knockout maintained very similar levels of AGT and ANG II levels to those of wild-type mice, suggesting that AGT in the kidney is derived directly from liver AGT and it is not required for ANG II production in the kidney [94••] . In liver-specific AGT-KO mice, AGT and ANG II levels in the kidney were almost completely abolished [94••] . Thus, the study of Matsusaka et al. strongly supports the concept that liver-derived AGT is the primary source of intrarenal AGT and ANG II proteins. Furthermore, since podocyte injury markedly increases intratubular and urinary AGT proteins and AGT proteins were not detected in the proximal tubule of megalin-KO mice, liver AGT is clearly filtered through the glomerulus and taken up by the proximal tubules via a megalin-mediated mechanisms [94••, 95] .
So, how to reconcile the findings of Kobori et al. and Matsusaka et al. remains unclear. Both studies are strongly supported by data obtained from their experimental or animal models. It is very likely that liver-derived AGT remains to be the primary source of AGT and ANG II in the kidney via glomerular filtration and the megalin-mediated uptake mechanism at least under physiological conditions [94••, 95] . In pathophysiological conditions, especially in ANG IIdependent hypertension, however, intratubular and intracellular expression or synthesis of AGT mRNAs, AGT and ANG II proteins are significantly augmented especially in the proximal tubules of the kidney [55, [107] [108] [109] 110 •]. Augmentation of intratubular and intracellular AGT expression, AGT and ANG II production undoubtedly provides a powerful feedforward mechanism for ANG II to maintain high blood pressure and induce kidney injury in ANG IIdependent hypertension.
Prorenin and Renin
Prorenin is the Binactive^precursor of renin, which is primarily and constitutively synthesized in, and released from the juxtaglomerular (JGA) cells in the kidney [111] . Recent studies suggests that prorenin and its receptors (PRR) are also expressed and/or localized in the collecting duct cells of the medulla [91, 92, 112••] . However, other extrarenal tissues or fluid compartments, including eyes, adrenal glands, the ovarian follicle, amniotic fluid, and vitreous fluid in diabetes with proliferative retinopathy, also contain high levels of prorenin than plasma [113] [114] [115] [116] . The plasma levels of prorenin are estimated to be about 10-fold higher than those of renin [116] . With a molecular weight of ∼48 kDa, circulating renin is expected to be filtered through the glomeruli, but prorenin, with a molecular weight of ∼54 kDa, may not cross the glomeruli, because the molecular wt. cutoff size of various proteins or peptides for glomerular filtration is previously thought to be ∼50 kDa [96••] . Moe et al. previously reported that renin activity and mRNAs were detectable in cultured rabbit proximal tubule cells, but its mRNAs were not detected in microdissected rat proximal tubules [117] . Chen et al. measured renin activity and renin mRNA levels in microdissected proximal convoluted tubules (PCT), proximal straight tubules (PST), outer medullary collecting ducts (OMCD), and glomeruli, and found that renin mRNAs were consistently detectable in PCT and PST, but not in OMCD [118] . Whether prorenin and/or renin are expressed intratubularly, or taken up in the proximal tubules of the kidney remains an issue of current debate as well. There is evidence that prorenin and renin detected in the proximal tubules of the kidney may be due to the uptake of circulating prorenin and renin after glomerular filtration and/or interstitial renin secreted from the JGAs [119] . For example, Taugner et al. previously demonstrated that the reabsorptive pinocytosis of the filtered renin or 125 I-labeled renin was the primary source of intratubular renin in the kidney, which was accumulated in the apical region of the proximal convoluted tubules [119, 120] .
More recently, Roksnoer et al. studied the glomerular filtration of fluorescently labeled renin and prorenin using multiphoton microscopy in C57BL/6J mice with or without damage to the glomerular filtration barrier by treating the animals with doxorubicin [96••] . This study provides a number of new insights on the origin of intratubular renin and prorenin in the proximal tubules of the kidney and the urine. First, intravital multiphoton imaging of fluorescently labeled renin (∼48 kDa), prorenin (∼54 kDa), and albumin (∼67 kDa) revealed that all three proteins were filtered through the glomeruli though with greater filtration rates for renin and prorenin than albumin, and all were significantly increased after administration of doxorubin to induce injury to the glomerular filtration barrier. More importantly, nearly all filtered renin and prorenin were subsequently reabsorbed along the nephron, primarily in the proximal tubules, and none appeared in urine [96••] . Second, these authors determined the excretion of renin and prorenin in a CYP1a1-Ren2 transgenic rats, a model of prorenin overexpression in the liver [96••] . In these rats, circulating prorenin and renin were elevated by 200 and 20 %, respectively, but renin and prorenin were not detectable in the urine, suggesting a complete tubular reabsorption of filtered renin and prorenin [96••] . Finally, in patients with Dent's disease, which is associated with defective megalin-mediated uptake of low molecular weight proteins in the proximal tubules, Roksner et al. found that urinary excretion of renin, prorenin, AGT, and albumin were 20-to 40-fold higher in these patients than those of normal subjects [96••] . While renin, prorenin, and AGT may not be detectable in the urine of normal humans, they are easily detectable in patients with Dent's disease. Together, these findings provide strong evidence that circulating renin and prorenin clearly cross the glomeruli filtration barrier and almost completely reabsorbed in the proximal tubules via a megalin-dependent pathway under physiological conditions.
Angiotensin II
Intratubular and intracellular expression and synthesis of AGT, renin and prorenin, and ACE no doubt contribute to high levels of ANG II levels in the kidneys of normal rats or mice [53, 62, 87, [121] [122] [123] . ANG II levels are further augmented in the kidneys of animal models of ANG II-dependent hypertension, despite of markedly suppression of plasma renin activity and JGA renin in the kidney [83, 86, 87, 91] . Three potential mechanisms may likely explain these findings. The foremost is probably due to the fact that the kidney, especially the proximal tubules, express all major components of the RAS necessary for the generation of ANG II intratubularly and intracellularly [52, 53, 55, 62, 63] . The second mechanism is that the proximal tubules have a greater capacity to take up circulating ANG II via AT 1 (AT 1a ) receptor-mediated mechanisms [77, 87, 88, 98] . The third mechanism is that rather than being downregulated by high levels of circulating and intrarenal ANG II, AGT mRNA expression and proteins are markedly augmented in ANG IIinduced hypertension [53, 83, 107] . The reported increase in the expression or secretion of renin and prorenin from the inner medullary collecting ducts may also contribute to high intratubular and urinary ANG II levels in 2K1C or ANG IIinfused hypertensive rats [84, 91, 93, 124] . Thus, it is likely that the combination of these rather than a single mechanism may explain the high levels of intrarenal ANG II in health and hypertensive diseases.
We and others have studied whether AT 1 (AT 1a ) receptormediated uptake of circulating ANG II by the kidney, especially by the proximal tubules, plays a key role in intrarenal accumulation of circulating ANG II (Fig. 2) [77, 86-88, 99, 125, 126] . The early evidence that the kidney accumulates the circulating ANG II was provided by von Thum et al. and Zou et al. who systemically infused exogenous ANG II to raise the plasma ANG II level equivalent to that seen in 2K1C renal hypertensive rats [97] . These authors showed that despite that plasma renin activity was markedly suppressed by 80 %, intrarenal ANG II levels of the contralateral kidneys of 2K1C and ANG II-infused rats greatly exceeded that of sham control or uninephrectomized control animals. Several groups have subsequently confirmed these findings [86, [98] [99] [100] 127] . However, the site(s) or cell type(s) responsible for intrarenal accumulation of ANG II were not determined by the whole-kidney approach.
We reasoned that among all cell types or tubular segments in the kidney, the proximal tubules express abundant high affinity and high density of AT 1 (AT 1a ) receptors in apical and basolateral membranes and robust multi-ligand endocytic receptor megalin [128] [129] [130] [131] [132] [133] [134] . ANG II binds AT 1 (AT 1a ) receptors or megalin and internalizes with AT 1 (AT 1a ) receptors or megalin, with subsequent accumulation within the proximal tubule cells [128] [129] [130] 135] . Indeed, fluorescently labeled ANG II (FITC-ANG II) was found to bind and internalized to the endosomal and nuclear compartments with AT 1 (AT 1a ) receptors in cultured rabbit and mouse proximal tubule cells [128] [129] [130] . In addition to AT 1 (AT 1a ) receptors, the microtubule-, megalin-, and caveolin 1-dependent mechanisms may also be involved in the proximal tubule uptake of ANG II [129, 136••, 137••] . This phenomenon is not only applied to cultured proximal tubule cells, since AT 1 -, megalin-, and caveolin 1-mediated uptake of ANG II by the proximal tubules may be also reproduced in the proximal tubules of the rat and mouse kidney. In an earlier study, we systemically infused [Val 5 ]-ANG II into the rats for 2 weeks to induce ANG IIdependent hypertension and isolated and purified light endosomes from the superficial cortex of the kidney to measure endosomal ANG II levels [87] . The level of ANG II was almost 10 times higher in the endosomal compartments of ANG II-infused rats, where ANG II was colocalized with internalized AT 1a receptors [87] . As the proximal tubule uptake of ANG II was blocked by the AT 1 receptor blocker candesartan, the results suggest that AT 1 receptors may mediate this response [87] . In subsequent studies, we infused unlabeled [88] , radiolabeled [ 125 I]-ANG II (Fig. 2) [77] , or fluorescently Alexa 488-labeled ANG II [137••] in wild-type C57BL/6J and AT 1a receptor-or caveolin 1-knockout mice, respectively, to compare the proximal tubule uptake responses of ANG II in the kidney. We found that deletion of AT 1a receptors markedly decreased ANG II uptake in the proximal tubules by 90 % [77, 88] , whereas deletion of caveolin 1 reduced ANG II uptake by almost 50 % (Fig. 3 ) [137••] . Taken together, these studies provide strong evidence that the circulating and/or paracrine ANG II is taken up by the proximal tubules in the kidney via the AT 1 (AT 1a )-, megalin-, and/or caveolin 1-mediated mechanisms. Thus, the AT 1 (AT 1a ) receptor-and multi-ligand endocytic receptor megalin-mediated uptake of circulating ANG II may also significantly contribute to the normal levels of intrarenal ANG II found in mice with kidney or proximal tubule-specific ACE knockout mice [138, 139••, 140] , as well as augmented intrarenal ANG II levels in ANG II-infused hypertensive animals [77, 87, 88, 97, 98] .
Novel Biological and Physiological Roles of Internalized and/or Intracellular ANG II in the Proximal Tubules of the Kidney
It is now well accepted that the circulating endocrine and local tissue paracrine ANG II plays the key role in the regulation of proximal tubular Na [148] or transcriptional effects on transforming growth factor-β1 (TGF-β1), macrophage chemoattractant protein-1 (MCP-1), and NHE3 in freshly isolated nuclei from the superficial cortex of the kidney [150] . Microinjection of ANG II directly into vascular smooth muscle cells has previously been shown to increase cytoplasmic and nuclear calcium responses [151] . The isolated nuclei maintain intact nuclear membranes, but devoid of cell surface membranes or other intracellular organelles, should be an ideal approach to test nuclear actions of intracellular ANG II. A high level of FITC-or [
125 I]-labeled ANG II binding sites specific to AT 1 receptors was demonstrated in the isolated nuclei. Incubation of these isolated nuclei with ANG II significantly increased in vitro transcription of mRNAs for TGF-β1, MCP-1, and NHE3 [150] . These results suggest that ANG II may directly stimulate nuclear AT 1 receptors to induce transcriptional responses in the proximal tubules of the kidney. Chappell's group has also demonstrated AT 1 , AT 2 , and ANG [1] [2] [3] [4] [5] [6] [7] receptor binding sites in isolated sheep renal cortical nuclei, and showed that ANG II stimulated the nuclear AT 1 receptors to increase superoxide production, whereas stimulation of nuclear AT 2 or ANG (1-7) receptors increased nitric oxide production [66••, 152, 153] . In the heart, Tadevosyan et al. confirmed that cardiomyocytes also contain ANG II receptors in the nuclear membranes that ANG II regulates the transcriptional responses [154] . In addition to the nuclei, ANG II and its AT 1 and/or AT 2 receptors have been identified recently in the isolated mitochondria of liver and kidney epithelial cells, where interactions between ANG II and these receptors significantly altered superoxide and nitric oxide production [155••] . These studies along with ours strongly suggest an important intracellular and nuclear role for internalized or intracellular ANG II.
Whether internalized and/or intracellular ANG II has a physiological role in the regulation of proximal tubular Na + reabsorption and blood pressure is very difficult to be studied using conventional approaches. The argument against a role for internalized and/or intracellular ANG II is that it is impossible to separate the effects and/or signaling responses induced by intracellular ANG II via its cytoplasmic and nuclear receptors from those mediated by the cell surface receptors. Cook et al. have been instrumental in designing and developing an intracellular cyan fluorescent ANG II fusion protein, enhanced cyan fluorescent protein (ECFP)/ANG II, for a number of proof of concept studies [156, 157, 158••] . These authors showed that overexpression of ECFP/ANG II in COS-7, CHO-K1, and rat vascular smooth muscle cells significantly enhanced cell proliferation [156, 157] , whereas global overexpression of ECFP/ANG II in a transgenic mouse model increased blood pressure and induced intrarenal microangiopathy [158••] . In the kidney, we demonstrated that overexpression of ECFP/ANG II selectively in proximal tubules of the kidney using the sglt2 promoter and the adenoviral transfer approach increased proximal tubular Na + reabsorption and blood pressure in rats and mice (Fig. 4) Approximately 70 % of the filtered Na + and fluid load is reabsorbed by the proximal tubules of the kidney, thus increased proximal tubular reabsorption of Na + and fluid from the kidney by a few percent points may lead to body salt and fluid retention and therefore contributes to hypertension. Although all antiporters (or exchangers) and cotransporters play important roles in this proximal tubular function [17] , the most important Na + transporter in proximal tubules remains to be NHE3 [161, 162] . NHE3 belongs to the Na + /H + exchanger (NHE) gene family with nine isoforms [161, 162] , and it is primarily localized in the AP membranes of small intestines and the proximal tubules [163] . In the kidney, the loop of Henle (mTAL) also expresses low levels of NHE3 [162] . In proximal tubules, the key function of NHE3 is to secrete hydrogen ions in exchange for luminal Na + , contributing to reabsorbing ∼60 % of filtered Na + and ∼80 % of filtered sodium bicarbonate in the kidney [27, [164] [165] [166] . The importance of intestinal and kidney NHE3 in maintaining body salt and fluid balance and blood pressure homeostasis was directly tested by Shull's group in global Nhe3 −/− mice and Nhe3 −/− mice with transgenic rescue of the NHE3 gene selectively in small intestines (tgNhe3
) [167] [168] [169] . Genetic knockout of the NHE3 gene in mice leads to 50 % decreases in Na + and fluid, and ∼80 % decreases in sodium bicarbonate reabsorption in proximal convoluted tubules, causes renal salt wasting, and significantly decreases basal blood pressure [27, 28, 170, 171] . These phenotypes are accompanied by absorptive defects in the intestines resulting in moderate diarrhea due to intestinal NHE3 deletion [27] . Although Nhe3 −/− mice with transgenic rescue of the NHE3 gene in small intestines tolerate Na + depletion or loading better than Nhe3 −/− mice, their basal blood pressure remains almost as low as in Nhe3 −/− mice [171] .
These studies strongly suggest that NHE3 in the proximal tubules of the kidney plays an important role in basal blood pressure regulation. NHE3 is a major target of circulating, paracrine, and intracellular ANG II in the proximal tubules of the kidney. (NCC) in the distal convoluted tubule and epithelial Na + channel subunits in both cortex and medulla [182••] . In the absence of the changes in blood pressure and/or GFR, low doses of ANG II infusion provoked multiple transporter proteins trafficking to brush border membranes [183] or increase NHE3 abundance in the proximal tubules [175•] . These studies indicate that at physiological or subpressor levels, ANG II [124] increases NHE3 expression and activity in the proximal tubules of the kidney, contributing to normal blood pressure homeostasis. However, most of previous studies did not directly determined the specific roles of NHE3 in mediating the effects of ANG II in the proximal tubules of the kidney and the development of ANG II-dependent hypertension using mutant NHE3 animal models.
Recently, we have studied the role of NHE3 in ANG IIdependent hypertension using global Nhe3 significantly elevated plasma ANG II and aldosterone levels, and marked upregulation in aquaporin 1, the Na + /HCO3-cotransporter, the α1 subunit isoform of Na + /K + -ATPase, protein kinase Cα, MAP kinases ERK1/2, and glycogen synthase kinase 3 α/β in the renal cortex in these mice (p < 0.01). These results suggest that these compensatory RAS and transporter responses were insufficient to maintain normal basal blood pressure in these mice [30••, 31••]. In response to a pressor dose of ANG II infusion for 2 weeks (1.5 mg/kg/day, i.p.), systolic and mean arterial blood pressure and other renal cortical transporter and signaling proteins were increased in wildtype mice, as expected. However, these responses to ANG II were all significantly attenuated in both Nhe3 −/− and tgNhe3 
Conclusions
In summary, this overview article has provided an update on recent studies on the sources and roles of proximal tubule ANG II and NHE3 in renal physiology and hypertension. To date, it remains an issue for continuous debate on whether ANG II in the proximal tubules of the kidney is primarily due to local intratubular and intracellular formation or derived from the uptake of circulating and paracrine ANG II. The available evidence, however, appears to support the concept that both intratubular/intracellular expression (i.e., local onsite formation) and AT 1 (AT 1a ) receptor-and/or megalin-mediated uptake of circulating ANG II contribute to high levels of ANG II in the proximal tubules of the kidney. The current view suggests that under physiological conditions, nearly all major components of the RAS including AGT, prorenin, renin, ANG I, and ANG II with a molecular weight smaller than albumin will cross the glomerular filtration barrier and almost completely take up by the proximal tubules of the kidney via the powerful endocytic machinery. Although circulating ACE with a molecular weight of ∼130 kDa is unlikely filtered by the glomerulus, ACE is abundantly expressed intracellularly and on luminal apical membranes, so that ANG I and ANG II are generated intracellularly and in the lumen of the proximal tubules. ANG II, via AT 1 (AT 1a ) receptor activation and stimulation of the expression or activity of NHE3 as well as other Na + transporters or cotransporters, plays a key role in the physiological regulation of proximal tubule Na + and fluid reabsorption and contributes to normal blood pressure homeostasis. During the development of hypertension, especially in all forms of ANG II-dependent hypertension, the expression of AGT, prorenin and (Pro)renin receptors, and ACE in the kidney is upregulated rather than downregulated as expected, which further increases ANG II generation in the kidney. Furthermore, hypertension is expected to impair the glomerular filtration barrier, which further augments the glomerular filtration of circulating AGT, prorenin, renin, ANG I, and ANG II and subsequent uptake in the proximal tubules of the kidney, as well as in the distal nephron segments. Together, increased expression or synthesis and augmented uptake of major components of the RAS in the proximal tubules and other tubular segments of the kidney provide a powerful feedforward mechanism for the development and maintenance of ANG II-induced hypertension. Thus, it is necessary to develop new pharmacological strategies or approaches to target this feedforward mechanism in order to prevent and treat ANG II-induced renal injury and hypertension. 
